Company news
Galmed Pharmaceuticals Ltd. news in 2020
Galmed Pharmaceuticals Ltd.'s news releases, calls and decks from 2020, newest first.
Galmed to add Open Label Part to ARMOR Study; First Read-out Expected in Q4 2021
December 16, 2020
Galmed Pharmaceuticals Reports Third Quarter 2020 Financial Results
November 11, 2020
Galmed and MyBiotics to Collaborate in Development of Bespoke Microbiome Signature for Aramchol
November 8, 2020
Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
August 5, 2020
Galmed Pharmaceuticals Announces Acceleration of its New Clinical Amilo-5MER program
August 5, 2020
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results
May 13, 2020
Galmed Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Business Update on Thursday May 14
May 6, 2020
Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2019 Financial Results
March 11, 2020
Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2019 Financial Results and Provide Business Update on Thursday March 12
March 4, 2020
Decks in 2020
- Investor Presentation (August 2020)
Investor deck · 24 slides · Aug 6, 2020